Segment Information by Division

January 1 to December 31

 (XLS:) Download XLS

 

  

 

€ million

  

Sili­cones

  

Poly­mers

  

Bio­solutions

  

Poly­silicon

  

Other

  

Discon­tinued opera­tions

  

Consoli­dation

  

Group

1

Intangible assets; property, plant and equipment; investment property

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 21.

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2018

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

External sales

  

2,499.5

  

1,258.2

  

227.0

  

823.5

  

170.6

  

–

  

–

  

4,978.8

Internal sales

  

0.1

  

24.0

  

–

  

–

  

–

  

–

  

-24.1

  

–

Total sales

  

2,499.6

  

1,282.2

  

227.0

  

823.5

  

170.6

  

–

  

-24.1

  

4,978.8

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

536.7

  

108.0

  

9.8

  

-257.3

  

-6.8

  

–

  

-0.8

  

389.6

Depreciation and impairment losses / reversals

  

79.9

  

39.7

  

13.7

  

329.7

  

77.4

  

–

  

–

  

540.4

EBITDA

  

616.6

  

147.7

  

23.5

  

72.4

  

70.6

  

–

  

-0.8

  

930.0

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

31.8

  

–

  

–

  

–

  

99.9

  

–

  

–

  

131.7

Impairment of fixed assets

  

–

  

-1.4

  

–

  

–

  

–

  

–

  

–

  

-1.4

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Asset additions1

  

222.7

  

71.0

  

17.9

  

62.2

  

87.1

  

–

  

–

  

460.9

Additions to financial assets

  

–

  

–

  

–

  

–

  

–

  

–

  

–

  

–

Asset additions

  

222.7

  

71.0

  

17.9

  

62.2

  

87.1

  

–

  

–

  

460.9

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,770.3

  

686.3

  

207.1

  

2,262.7

  

2,192.5

  

–

  

-0.2

  

7,118.7

Liabilities (Dec. 31)

  

826.3

  

307.6

  

78.2

  

712.4

  

2,048.9

  

–

  

-0.2

  

3,973.2

Net assets (Dec. 31)

  

944.0

  

378.7

  

128.9

  

1,550.3

  

143.6

  

–

  

–

  

3,145.5

Investments in joint ventures and associates included in net assets (Dec. 31)

  

41.7

  

–

  

–

  

–

  

616.6

  

–

  

–

  

658.3

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

60.9

  

30.0

  

6.3

  

32.8

  

34.6

  

–

  

–

  

164.6

Employees (Dec. 31)

  

5,114

  

1,600

  

709

  

2,549

  

4,570

  

–

  

–

  

14,542

Employees (average)

  

4,990

  

1,575

  

665

  

2,548

  

4,523

  

–

  

–

  

14,301

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

2017

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

External sales

  

2,200.0

  

1,225.6

  

205.8

  

1,101.3

  

150.8

  

–

  

–

  

4,883.5

Internal sales

  

0.2

  

19.5

  

0.1

  

22.7

  

18.0

  

–

  

-19.8

  

40.7

Total sales

  

2,200.2

  

1,245.1

  

205.9

  

1,124.0

  

168.8

  

–

  

-19.8

  

4,924.2

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT

  

362.2

  

168.1

  

26.1

  

-87.6

  

-48.2

  

–

  

3.1

  

423.7

Depreciation and impairment losses / reversals

  

82.7

  

37.5

  

11.4

  

378.0

  

80.8

  

–

  

–

  

590.4

EBITDA

  

444.9

  

205.6

  

37.5

  

290.4

  

32.6

  

–

  

3.1

  

1,014.1

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

EBIT includes:

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Result from investments in joint ventures and associates

  

2.0

  

–

  

–

  

–

  

40.0

  

–

  

–

  

42.0

Impairment of fixed assets

  

–

  

–

  

–

  

–

  

–

  

–

  

–

  

–

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Asset additions1

  

142.8

  

48.1

  

15.7

  

57.6

  

62.5

  

19.5

  

–

  

346.2

Additions to financial assets

  

–

  

–

  

–

  

–

  

0.1

  

–

  

–

  

0.1

Asset additions

  

142.8

  

48.1

  

15.7

  

57.6

  

62.6

  

19.5

  

–

  

346.3

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Assets (Dec. 31)

  

1,471.1

  

609.3

  

157.7

  

2,395.3

  

2,202.4

  

–

  

-0.1

  

6,835.7

Liabilities (Dec. 31)

  

688.8

  

270.9

  

66.0

  

759.6

  

1,881.2

  

–

  

-0.1

  

3,666.4

Net assets (Dec. 31)

  

782.3

  

338.4

  

91.7

  

1,635.7

  

321.2

  

–

  

–

  

3,169.3

Investments in joint ventures and associates included in net assets (Dec. 31)

  

9.9

  

–

  

–

  

–

  

554.7

  

–

  

–

  

564.6

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Research and development expenses

  

58.6

  

29.3

  

6.0

  

22.6

  

36.6

  

–

  

–

  

153.1

Employees (Dec. 31)

  

4,737

  

1,539

  

533

  

2,538

  

4,464

  

–

  

–

  

13,811

Employees (average)

  

4,708

  

1,519

  

528

  

2,527

  

4,441

  

–

  

–

  

13,723

todo Vorjahresvergleich